Matthew Plavan
2015 - Cesca Therapeutics
In 2015, Matthew Plavan earned a total compensation of $1M as CEO thru October 28, at Cesca Therapeutics, a 2% decrease compared to previous year.
Compensation breakdown
Option Awards | $304,000 |
---|---|
Salary | $142,000 |
Other | $560,000 |
Total | $1,006,000 |
Plavan received $560K in other compensation, accounting for 56% of the total pay in 2015.
Plavan also received $304K in option awards and $142K in salary.
Rankings
In 2015, Matthew Plavan's compensation ranked 7,924th out of 13,638 executives tracked by ExecPay. In other words, Plavan earned more than 41.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,924 | 42nd |
Manufacturing | 3,009 | 42nd |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 396 | 48th |
Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 130 | 44th |
Laboratory Apparatus and Furniture | 4 | 71st |
Plavan's colleagues
We found seven more compensation records of executives who worked with Matthew Plavan at Cesca Therapeutics in 2015.
2015
Robin Stracey
Cesca Therapeutics
Chief Executive Officer
2015
Dan Bessey
Cesca Therapeutics
Chief Financial Officer
2015
Ken Harris
Cesca Therapeutics
Former President
2015
Mitchel Sivilotti
Cesca Therapeutics
Former Chief Biologist
2015
Ray DeGrella
Cesca Therapeutics
VP, Quality & Regulatory Affairs thru September 10,
2015
Michael Bruch
Cesca Therapeutics
Chief Financial Officer
2015
Kim Ellner
Cesca Therapeutics
VP, Manufacturing & Global Supply Chain
News
Arcadia Biosciences CEO Matthew Plavan's 2021 pay jumps 102% to $1.6M
April 19, 2022
Arcadia Biosciences CEO Matthew Plavan's 2020 pay jumps 37% to $794K
April 20, 2021
Arcadia Biosciences CEO Matthew Plavan's 2019 pay stays at $581K
April 17, 2020
Arcadia Biosciences CEO Rajendra Ketkar's 2018 pay jumps 40% to $904K
April 18, 2019